Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7083554
Reference Type
Journal Article
Title
Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant Staphylococcus aureus and Acinetobacter baumannii
Author(s)
Whitt, J; Duke, C; Sumlin, A; Chambers, SA; Alnufaie, R; Gilmore, D; Fite, T; Basnakian, AG; Alam, MA; ,
Year
2019
Is Peer Reviewed?
1
Journal
Molecules
ISSN:
1420-3049
Publisher
MDPI
Location
BASEL
Volume
24
Issue
11
Language
English
PMID
31146470
DOI
10.3390/molecules24112051
Web of Science Id
WOS:000472631000024
Abstract
Microbial resistance to drugs is an unresolved global concern, which is present in every country. Developing new antibiotics is one of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat bacterial resistance to drugs. Based on our lead molecules, we report the synthesis and antimicrobial studies of 27 new pyrazole derivatives. These new coumarin-pyrazole-hydrazone hybrids are readily synthesized from commercially available starting materials and reagents using benign reaction conditions. All the synthesized molecules were tested against 14 Gram-positive and Gram-negative bacterial strains. Several of these molecules have been found to be potent growth inhibitors of several strains of these tested bacteria with minimum inhibitory concentrations as low as 1.56 g/mL. Furthermore, active molecules are non-toxic in in vitro and in vivo toxicity studies.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity